93 related articles for article (PubMed ID: 9004160)
1. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP mRNA expression of adult rat cardiac myocytes.
Yu JZ; Bondy GP; Allard MF; Thompson CR; Levin A; McManus BM
J Mol Cell Cardiol; 1996 Dec; 28(12):2429-41. PubMed ID: 9004160
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
4. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
5. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
6. Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo.
Skoumal R; Szokodi I; Aro J; Földes G; Göoz M; Seres L; Sármán B; Lakó-Futó Z; Papp L; Vuolteenaho O; Leppäluoto J; DeChâtel R; Ruskoaho H; Tóth M
Life Sci; 2007 Mar; 80(14):1303-10. PubMed ID: 17266992
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy.
Cavallero S; González GE; Puyó AM; Rosón MI; Pérez S; Morales C; Hertig CM; Gelpi RJ; Fernández BE
J Hypertens; 2007 Sep; 25(9):1940-50. PubMed ID: 17762660
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
9. Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
Ikeda K; Tojo K; Udagawa T; Otsubo C; Ishikawa M; Tokudome G; Hosoya T; Tajima N; Nakao K; Kawamura M
Hypertens Res; 2008 Apr; 31(4):693-706. PubMed ID: 18633182
[TBL] [Abstract][Full Text] [Related]
10. [Role of endothelin-1 and its receptors on hypertrophy or proliferation of cultured cardial cells].
You HW; Chen X; You HJ; Zhang YQ; Cai Y; Liu GZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):520-3. PubMed ID: 16995305
[TBL] [Abstract][Full Text] [Related]
11. Increased insulin-like growth factor-I gene expression precedes left ventricular cardiomyocyte hypertrophy in a rapidly-hypertrophying rat model system.
Huang CY; Buchanan DL; Gordon RL; Sherman MJ; Razzaq J; White K; Buetow DE
Cell Biochem Funct; 2003 Dec; 21(4):355-61. PubMed ID: 14624474
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Ye P; Yang W; Wu SM; Sheng L
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level.
Feng B; Chen S; Chiu J; George B; Chakrabarti S
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1119-26. PubMed ID: 18413674
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
Weil J; Zolk O; Griepentrog J; Wenzel U; Zimmermann WH; Eschenhagen T
Cardiovasc Res; 2006 Feb; 69(2):412-22. PubMed ID: 16376326
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart.
Kruse JJ; Strootman EG; Bart CI; Visser A; Leer JW; Wondergem J
Int J Radiat Biol; 2002 Apr; 78(4):297-304. PubMed ID: 12020441
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
19. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle.
Jankowski M; Wang D; Mukaddam-Daher S; Gutkowska J
J Endocrinol; 2005 Jan; 184(1):209-17. PubMed ID: 15642797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
